More than 6 percent of people in their 60s have
mild cognitive impairment across the globe, and the condition becomes more common with age, according to the American Academy of Neurology.
The age - related decline in growth hormone and associated IGF - 1 has been linked to age - related muscle atrophy, increased adipose tissue, and neuronal dysfunction.2, 9 In fact, growth hormone replacement therapy in elderly men has been shown to increase lean body mass.9 Growth hormone therapy (1 mg / day — for 5 months) has also been used to improve
cognitive function in healthy adults and adults with
mild cognitive impairment.10 While only modest amounts of growth hormone cross the blood - brain barrier, IGF - 1, which is actually responsible for the
cognitive benefits, gets
across just fine.